Publicaciones en colaboración con investigadores/as de University Hospital of Zurich (7)

2024

  1. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

  2. Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet

    Pharmacological Research, Vol. 200

2022

  1. Correction to: Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel (Ophthalmology and Therapy, (2022), 11, 5, (1743-1766), 10.1007/s40123-022-00529-4)

    Ophthalmology and Therapy

  2. Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel

    Ophthalmology and Therapy, Vol. 11, Núm. 5, pp. 1743-1766

2021

  1. Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 17, Núm. 11, pp. 1327-1343

2020

  1. Hepatocyte KLF6 expression affects FXR signalling and the clinical course of primary sclerosing cholangitis

    Liver International, Vol. 40, Núm. 9, pp. 2172-2181

2017

  1. Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury

    Scientific Reports, Vol. 7, Núm. 1